GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » Pretax Margin %

Emcure Pharmaceuticals (NSE:EMCURE) Pretax Margin % : 11.71% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Emcure Pharmaceuticals's Pre-Tax Income for the three months ended in Dec. 2024 was ₹2,299 Mil. Emcure Pharmaceuticals's Revenue for the three months ended in Dec. 2024 was ₹19,626 Mil. Therefore, Emcure Pharmaceuticals's pretax margin for the quarter that ended in Dec. 2024 was 11.71%.

The historical rank and industry rank for Emcure Pharmaceuticals's Pretax Margin % or its related term are showing as below:

NSE:EMCURE' s Pretax Margin % Range Over the Past 10 Years
Min: 11.05   Med: 14.73   Max: 16.87
Current: 11.84


NSE:EMCURE's Pretax Margin % is ranked better than
64.68% of 974 companies
in the Drug Manufacturers industry
Industry Median: 6.085 vs NSE:EMCURE: 11.84

Emcure Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for Emcure Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Pretax Margin % Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Pretax Margin %
16.86 16.87 12.60 11.05

Emcure Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial 11.91 10.25 9.85 13.66 11.71

Competitive Comparison of Emcure Pharmaceuticals's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Emcure Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Emcure Pharmaceuticals's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emcure Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Emcure Pharmaceuticals's Pretax Margin % falls into.


;
;

Emcure Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Emcure Pharmaceuticals's Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=7272.28/65819.92
=11.05 %

Emcure Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=2299.19/19626.3
=11.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Emcure Pharmaceuticals  (NSE:EMCURE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Emcure Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Emcure Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines